X
Home > Journals > Endocrine, Metabolic and Immune Disorders Drug Targets Impact Factor, Quartile, Indexing, Ranking
Endocrine, Metabolic and Immune Disorders Drug Targets (EMIDDT) is a scholarly journal dedicated to publishing research in the field of Medicine, and Published by Bentham Science Publishers. The Print-ISSN of Endocrine, Metabolic and Immune Disorders Drug Targets is 18715303
Endocrine, Metabolic and Immune Disorders Drug Targets is published by Bentham Science Publishers, publishing since 2006. It covers research in Medicine.
The journal is indexed in Scopus.
| Journal title | Endocrine, Metabolic and Immune Disorders Drug Targets (EMIDDT) |
| Print ISSN | 18715303 |
| Online ISSN | 22123873 |
| Publisher Name | Bentham Science Publishers |
| Subject Category | Medicine |
| Access type | 🔒 Subscription |
| Status | 🟢 Active |
In the context of academic journals, "Metrics and Rankings" refer to various measures and evaluations used to assess the quality, influence, and impact of a journal.
Below are the metrics and rankings for the journal Endocrine, Metabolic and Immune Disorders Drug Targets
Abstracting and Indexing (A&I) refers to the processes that help organize and categorize academic journals, making them easier to find and access for researchers and scholars
| Abstracting and Indexing |
Add the app to your device for one-tap access.
